Bridgeworth, LLC Amgen Inc Transaction History

Bridgeworth, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $224,325 - $249,468	-956 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $28,682 - $35,197	-145 Reduced 13.17%	956 $225,000
Q4 2019 Jan 17, 2020	SELL	$189.21 - $243.2 $32,733 - $42,073	-173 Reduced 13.58%	1,101 $265,000
Q3 2019 Oct 15, 2019	BUY	$174.11 - $208.62 $221,816 - $265,781	1,274 New	1,274 $247,000
Q1 2019 Apr 24, 2019	SELL	$180.87 - $203.88 $333,343 - $375,750	-1,843 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$178.4 - $208.25 $7,671 - $8,954	-43 Reduced 2.28%	1,843 $217,000
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $66,148 - $74,573	357 Added 23.35%	1,886 $240,000
Q2 2018 Aug 15, 2018	SELL	$166.05 - $186.51 $74,556 - $83,742	-449 Reduced 22.7%	1,529 $282,000
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $335,132 - $391,644	1,978 New	1,978 $333,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Bridgeworth, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeworth, LLC with notifications on news.